IRDAI Lets Insurers Invest in New Development Bank Rs 25,000 Crore Maharajah INR Bonds

On 27 August 2026 the Insurance Regulatory and Development Authority of India issued circular reference IRDAI/F&I/CIR/INV/MISC/113/8/2026, addressed to every insurer in the country, permitting them to invest in the Maharajah INR Bonds proposed to be issued by the New Development Bank (NDB). The decision followed representations the regulator received from the industry, and it slots a brand new category of onshore rupee debt into the list of instruments a life or general insurer may legitimately hold against your policy. For an industry that manages a multi-lakh-crore investment book on behalf of policyholders, where that money is allowed to go is never a back-office detail. This deep dive explains the circular clause by clause, why a bond programme aimed at green and social projects reaches all the way down to your bonus statement, and the traps that separate what the circular actually says from what a mis-selling script might claim it says.

The headline figure is large: the NDB, the multilateral lender established by the BRICS nations, plans to raise INR 25,000 crore through these bonds over a five-year window. The proceeds are earmarked for financing and on-lending to sustainable development, sustainable infrastructure, and green and social projects inside India, with a portion for general corporate purposes. For a policyholder, the relevant question is not whether the NDB succeeds in raising the money, but whether the rupees backing your sum assured are now exposed to a new issuer, under what conditions, and with what protection.

The Rule / Product

The operative instrument is IRDAI circular IRDAI/F&I/CIR/INV/MISC/113/8/2026 dated 27 August 2026, titled "Investment in Maharajah INR Bonds issued by New Development Bank (NDB)". It does one narrow thing: it classifies these specific bonds as an "Approved Investment" for insurers, rather than leaving them in the lower-ranked "Other Investment" bucket that attracts tighter internal limits. The bonds themselves are onshore rupee instruments that fall within the definition of securities under the Securities Contracts (Regulation) Act, 1956, the same 70-year-old statute that defines what counts as a tradable security on an Indian exchange (see indiacode.nic.in for the Act text).

The permission is not unconditional. The 27 August 2026 circular attaches five cumulative conditions, and an insurer must satisfy every one of them before a single rupee moves:

Condition (c) is the quiet hinge of the whole circular. Section 27E of the Insurance Act, 1938 prohibits an insurer from directly or indirectly investing policyholders' funds outside India. Because the Maharajah bonds are onshore, rupee-denominated instruments issued into the domestic market, they sit on the correct side of that prohibition, which is precisely why a multilateral lender's paper can be held at all. Condition (b) matters just as much for timing: as of the 27 August 2026 circular, the permission is prospective, and no money can be committed until the Securities and Exchange Board of India clears the public issue under its own disclosure regime (sebi.gov.in). You can check IRDAI's own text of the circular at irdai.gov.in.

Why It Matters

An Indian insurer does not keep your premium in a drawer. Every rupee of a traditional or participating premium flows into a tightly regulated investment book, and the returns on that book are what ultimately pay your maturity benefit, your annual bonus, and the claim your family will one day file. The 27 August 2026 circular widens that book by one high-grade, rupee-denominated issuer, which is why the plumbing is worth understanding even though you will never buy a Maharajah bond yourself.

Three groups of policyholders feel the effect differently. Holders of with-profits or participating policies are the most directly exposed, because IRDAI's regulations require that at least 90 per cent of the surplus in a participating fund be distributed to policyholders, with no more than 10 per cent retained for shareholders. A new category of Approved Investment that offers steady rupee income therefore feeds, by that 90:10 rule, overwhelmingly into the bonuses declared on your policy rather than into shareholder pockets. If you hold such a policy, the ULIP versus mutual fund calculator is a useful way to see how the return on the underlying fund, not the label on the product, drives your outcome.

Second, the circular's condition (d) ties the bonds to the rating criteria for Approved Investments under Schedule III of the IRDAI (Actuarial, Finance and Investment Functions of Insurers) Regulations, 2024, which means only investment-grade paper qualifies. That rating gate is the same discipline that protects the solvency margin IRDAI polices under Section 64VA of the Insurance Act, 1938, where insurers must hold assets worth at least 150 per cent of their liabilities. A stronger, more diversified pool of Approved Investments supports that 150 per cent cushion, and a well-capitalised insurer is simply likelier to pay your claim on time. To understand how a rupee sum assured is sized in the first place, work through the human life value calculator before you compare it against what any single policy offers.

Third, condition (e) lets qualifying proceeds count as an infrastructure investment, which connects the circular to India's long-running shortfall in insurer money flowing into roads, grids and green projects as of 2026. Insurers are natural long-duration investors, and matching 20-year and 30-year liabilities to 5-year-plus infrastructure and green bonds is a textbook fit. The glossary entry on IRDAI sets out the regulator's dual mandate of development and protection, and this circular is development and protection working in the same clause.

Worked Numbers

Because the bonds had not been priced as of the 27 August 2026 circular, there is no published coupon to quote, and we will not invent one. What we can do is size the programme precisely from the figures in the circular and then anchor any yield illustration to a rate that is independently verifiable, flagging it clearly as a benchmark rather than the bond's actual coupon.

Start with the programme itself. The NDB intends to raise INR 25,000 crore over five years. Spread evenly, that is an average of INR 5,000 crore of new supply a year that insurers, banks and other institutions can bid for:

Now an illustrative return. Suppose a mid-sized insurer allocates INR 100 crore of its Approved Investment book to a tranche of these bonds. We have no coupon, so we use the Reserve Bank of India repo rate of 5.25 per cent, last set on 5 August 2026 (rbi.org.in/monetary-policy), purely as a conservative floor-of-the-market benchmark. On that assumption, the holding would throw off roughly INR 5.25 crore of interest a year, or about INR 26.25 crore of simple interest across the five-year window. The real figure will differ once SEBI clears the issue and the bond is priced, almost certainly above the repo rate for a corporate credit, but this frames the order of magnitude. For context, two active, government-set rupee rates that any Indian saver can verify today sit higher than the repo benchmark:

The point of the comparison is not that the bond will pay 7.7 per cent; it is that a AA-or-better rupee corporate bond from a multilateral issuer would realistically price somewhere in this rupee-rate landscape, and an insurer earning in that band inside a participating fund passes at least 90 per cent of the resulting surplus back to policyholders. If you want to see how a fixed coupon compounds against inflation over a policy term, the glossary entries on bond yield and yield to maturity explain why the coupon alone never tells the full story.

Pitfalls

The gap between what the 27 August 2026 circular says and what it might be made to sound like is where policyholders get hurt. These are the traps worth naming.

First, this is not a retail product. The circular IRDAI/F&I/CIR/INV/MISC/113/8/2026 permits insurers to invest; it says nothing about you buying a Maharajah bond directly. Any pitch that offers you "the new NDB insurance bond" as a policy add-on is misreading a regulator-to-insurer investment circular as a consumer product, and you should treat it as a red flag.

Second, "Approved Investment" does not mean risk-free or guaranteed. The label under Schedule III of the IRDAI (Actuarial, Finance and Investment Functions of Insurers) Regulations, 2024 is a prudential classification about eligibility and internal limits, not a sovereign guarantee. The bonds are obligations of the New Development Bank, not of the Government of India, and condition (d) of the 27 August 2026 circular leans on a credit rating that can be downgraded. A rating migration below the Schedule III threshold would change how an insurer may treat the holding.

Third, the infrastructure classification in condition (e) is conditional, not automatic. It applies only if the proceeds actually fund sub-sectors on the Finance Ministry's harmonised master list. Assuming every rupee of the INR 25,000 crore raise automatically counts as infrastructure, when a portion is explicitly reserved for general corporate purposes, overstates the regulatory benefit.

Fourth, the timeline is not now. As of 27 August 2026 the permission is prospective and gated behind condition (b), SEBI approval of the public issue. Until that clearance appears on sebi.gov.in, no insurer can commit policyholder money to these bonds, and any claim that the money is "already invested" is premature.

Fifth, do not confuse this circular with the traps that bite in health or traditional policies. Sub-limits, co-payments, pre-existing-disease waiting periods and room-rent caps live in your policy wording, not in an investment circular, and they erode your claim regardless of how well the insurer's bond book performs. The connection between the two is indirect: a solvent insurer pays claims, but no investment return overrides a room-rent cap written into your contract. Before you buy, price the actual cover using the term insurance premium calculator and read the sum assured definition so the number on your policy means what you think it means.

FAQ

Can I, as a retail investor, buy Maharajah INR Bonds?

Not through the 27 August 2026 IRDAI circular. That circular (reference IRDAI/F&I/CIR/INV/MISC/113/8/2026) only tells insurers they may hold these bonds as an Approved Investment. Whether any tranche is later offered to the public depends on the terms SEBI approves under condition (b), which had not been published as of the circular date.

What is the New Development Bank?

The New Development Bank, or NDB, is the multilateral development bank established by the BRICS group of nations. Under its INR 25,000 crore Maharajah INR Bond programme described in the 27 August 2026 circular, it plans to raise onshore rupee funding over five years to finance sustainable, green and social projects in India.

Will this circular change my premium or my bonus?

Not directly or immediately. Your premium is set by underwriting, not by one new bond. Over time, if insurers earn steady rupee income from these bonds inside a participating fund, the IRDAI 90:10 surplus-distribution rule channels at least 90 per cent of that surplus into policyholder bonuses, so the effect, if any, reaches you through the bonus rather than the premium.

Are these bonds backed by a Government of India guarantee?

No. The bonds are obligations of the New Development Bank. The 27 August 2026 circular's condition (a) refers to any Government of India norms governing the issuance, and condition (d) requires a qualifying credit rating under Schedule III of the 2024 regulations, but neither amounts to a sovereign guarantee.

When can insurers actually invest?

Only after condition (b) of the 27 August 2026 circular is met, meaning SEBI has approved the public issue. As of the circular date, the permission is prospective, so no policyholder money had moved into these bonds.

What does "Approved Investment" mean for my policy?

It is a prudential classification under Schedule III of the IRDAI (Actuarial, Finance and Investment Functions of Insurers) Regulations, 2024. Approved Investments attract more favourable internal limits than "Other Investments", which supports the 150 per cent solvency margin IRDAI requires under Section 64VA of the Insurance Act, 1938. A better-capitalised insurer is more likely to pay your claim without delay.

Why does the "onshore rupee" label matter so much?

Because Section 27E of the Insurance Act, 1938 prohibits insurers from investing policyholders' funds outside India. The Maharajah bonds are onshore, rupee-denominated securities under the Securities Contracts (Regulation) Act, 1956, which is exactly why condition (c) of the 27 August 2026 circular can be satisfied and why a multilateral lender's paper is eligible at all.